Product Information
Registration Status: ActiveMENVEO POWDER AND SOLUTION FOR SOLUTION FOR INJECTION is approved to be sold in Singapore with effective from 2012-01-20. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN14083P.
This product contains MENVEO 10 microgram conjugated to 16.7-33.3 microgram,(Mena Lyo) Meningococcal Group A Oligosaccharide Conjugated To Crm197 Protein 5 microgram conjudated to 7.1-12.5 microgram,(Mencwy) Meningococcal Group C Oligosaccharide Conjugated To Crm197 Protein 5 microgram conjugated to 3.3-8.3 microgram,(Mencwy) Meningococcal Group W-135 Oligosaccharide Conjugated To Crm197 Protein 5 microgram conjugated to 5.6-10 microgram, and (Mencwy) Meningococcal Group Y Oligosaccharide Conjugated To Crm197 Protein in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAMUSCULAR use.
This product is manufactured by GSK Vaccines S.r.l. (MenCWY Liquid) in ITALY, andGSK Vaccines GmbH (MenA Lyo) in GERMANY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.